BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19833452)

  • 1. [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis].
    Homer L; Muller M; Dupré PF; Lucas B; Pradier O
    J Gynecol Obstet Biol Reprod (Paris); 2009 Dec; 38(8):629-33. PubMed ID: 19833452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine sarcoma associated with tamoxifen use.
    Wysowski DK; Honig SF; Beitz J
    N Engl J Med; 2002 Jun; 346(23):1832-3. PubMed ID: 12050351
    [No Abstract]   [Full Text] [Related]  

  • 4. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
    Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
    Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
    Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
    Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine sarcoma after tamoxifen therapy for breast cancer.
    Samuji M; O'Sullivan R; Shireen R
    Ir Med J; 2013 Sep; 106(8):246. PubMed ID: 24282897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2006 Jun; 107(6):1475-8. PubMed ID: 16738185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.
    Altaras MM; Aviram R; Beyth Y
    Gynecol Oncol; 1991 Jun; 41(3):270. PubMed ID: 1869106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
    Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
    Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen-related uterine malignancies: carcinomas or sarcomas?
    Delaloge S; Pautier P; Duvillard P
    Int J Gynecol Cancer; 2004; 14(2):395. PubMed ID: 15086746
    [No Abstract]   [Full Text] [Related]  

  • 11. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].
    Saim M; Cote JF; Morel O; Malartic C; Akerman G; Gray F; Barranger E
    Gynecol Obstet Fertil; 2008 Feb; 36(2):166-168. PubMed ID: 18249575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of developing uterine sarcoma after tamoxifen use.
    Lavie O; Barnett-Griness O; Narod SA; Rennert G
    Int J Gynecol Cancer; 2008; 18(2):352-6. PubMed ID: 18334013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mixed Müllerian tumor of the uterus associated with tamoxifen therapy for breast cancer.
    Magnani KK; Dubey S; Rai S
    Indian J Pathol Microbiol; 2010; 53(4):886-7. PubMed ID: 21045469
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of uterine malignancies that develop during and following tamoxifen therapy.
    Ferguson SE; Soslow RA; Amsterdam A; Barakat RR
    Gynecol Oncol; 2006 May; 101(2):322-6. PubMed ID: 16352333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy.
    Okada DH; Rowland JB; Petrovic LM
    Gynecol Oncol; 1999 Dec; 75(3):509-13. PubMed ID: 10600318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tamoxifen and breast cancer].
    Nechushtan H; Peretz T
    Harefuah; 2002 Aug; 141(8):718-20, 761, 760. PubMed ID: 12222137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.
    Yildirim Y; Inal MM; Sanci M; Yildirim YK; Mit T; Polat M; Tinar S
    Int J Gynecol Cancer; 2005; 15(6):1239-42. PubMed ID: 16343223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.